Zealand Pharma Announces Enrollment of Last Patient Needed for Interim Analysis of EASE-SBS 1 Phase 3 Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome

https://www.globenewswire.com/news-release/2021/12/16/2353232/0/en/Zealand-Pharma-Announces-Enrollment-of-Last-Patient-Needed-for-Interim-Analysis-of-EASE-SBS-1-Phase-3-Trial-Assessing-Glepaglutide-in-Patients-with-Short-Bowel-Syndrome.html

press release